Kathleen P. Gallagher
CIK 2048409 · See Remarks · last filed 2026-04-22
Kathleen P. Gallagher is a corporate insider who has filed 17 SEC Form 4 insider transactions across 2 companies since 2025. The most recent filing, for RNA, was dated Apr 22, 2026. Across all open-market trades the lifetime net is −$1.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.51M
2
17
-$1.22M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RNA | See Remarks | 131,361 | $11.49 | $1.51M | -$1.22M | 11 | 2026-04-22 |
| Avidity Biosciences, Inc. (RNAM) Delisted | Chief Program Officer | 0 | — | — | $0 | 1 | 2026-02-27 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-22 | RNA | Grant (A) | +102,500 | $0 | EDGAR |
| 2026-02-27 | Avidity Biosciences, Inc. (RNAM) Delisted | Disp (D) | −80,303 | $0 | EDGAR |
| 2025-12-19 | RNA | Mixed | +30,634 | -$2.97M | EDGAR |
| 2025-09-02 | RNA | Sell (S) | −188 | -$8.9K | EDGAR |
| 2025-06-18 | RNA | Sell (S) | −911 | -$27.5K | EDGAR |
| 2025-06-17 | Avidity Biosciences, Inc. (RNAM) Delisted | Notice (144) | −911 | -$27.1K | EDGAR |
| 2025-06-04 | RNA | Mixed | — | -$93.0K | EDGAR |
| 2025-06-02 | Avidity Biosciences, Inc. (RNAM) Delisted | Notice (144) | −5,875 | -$182.0K | EDGAR |
| 2025-05-02 | RNA | Mixed | — | -$92.5K | EDGAR |
| 2025-05-01 | Avidity Biosciences, Inc. (RNAM) Delisted | Notice (144) | −5,875 | -$191.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.